Cover

Experimental Models for Renal Diseases

Pathogenesis and Diagnosis

Editor(s): Herrera G.A. (Tempe, Ariz.) 
Table of Contents
Vol. 169, 2011
Section title: Paper

HIV-Associated Nephropathy: Experimental Models

Avila-Casado M.C. · Fortoul T.I. · Chugh S.S.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Since 1984 reports of renal involvement in AIDS patients have been presented in the literature. Different forms of renal disease were noted in the AIDS population including those related to systemic and local renal infections, tubulointerstitial disease, renal involvement by neoplasm and glomerular disease including collapsing glomerulopathy (CG). HIV-associated nephropathy (HIVAN) has been demonstrated to be more severe in the black population. HIVAN is the most common cause of renal failure in HIV-1–seropositive patients. The term HIVAN is reserved for the typical histopathological form of focal and segmental glomerulosclerosis (FSGS) characterized by the findings of coexistent glomerular and severe tubulointerstitial disease. In both humans and the murine model, glomerular lesions include FSGS, glomerular collapse and podocyte hyperplasia. The tubulointerstitial damage as well as the glomerular collapse can also be seen in non-HIV primary collapsing GN, raising the question of common mechanisms to HIV and other non-identified viral agents related to the development of the disease. Although controversial, increasing evidence supports a direct effect of the virus on renal cells either as a result of exposure to viral proteins or direct renal parenchyma infection. The use of a HIV-1 transgenic mouse model has demonstrated a direct etiologic link between HIV-1 expression in kidney and the development of HIVAN with unique viral-host interactions, which depend at the same time on stimulating features of the virus and the individual nature of the host response. The infection of renal cells by HIV-1 could be detected by reverse transcription-polymerase chain reaction (RT-PCR) of gag RNA at a low level. Some studies using an HIV-1 transgenic mouse model have demonstrated that expression of HIV- 1 in the kidney is required for the development of HIVAN. The final common pathwayin the development of HIV-associated nephropathy islikely to involve alterations in the patterns of gene expressionof renal parenchyma cells by cytokines and growthfactors, leading to interstitial fibrosis and enhanced glomerularmatrix synthesis. The nature of the host response toviral infection is critical to the development of nephropathy.HLA-linked responses particular to a subset of blacks may explain some of the epidemiologic features of HIVAN. There may also be biological heterogeneity in the strains of HIV-1 that could account for a particular renotropic strain. HIV strains from different parts of the world may vary by as much as 15% at the level of nucleotide sequence. The infectivity of human immunodeficiency virus (HIV-1) in human glomerular cells has been evaluated by exposing homogeneous cultures of human glomerular capillary endothelial, mesangial and epithelial cells to HIV in vitro. The mechanism of access of HIV into glomerular endothelial and mesangial cells is unknown up to now; HIV is generally infectious for cells expressing the CD4 antigen in their cell membrane. Other modes of HIV entry into cells independent of the CD4 receptor are possible through mechanisms involving Fc-receptors or coinfection with other enveloped viruses such as HTLV-l. Our understanding of the pathogenesis of HIVAN has been aided by the development of a transgenic model. The curious fact that only 3 of 8 founded transgenic lines developed nephropathy emphasizes that the expression of viral gene products per se is not sufficient to produce nephropathy. Human renal epithelium does not express CD4 receptors and in vitro attempts to infect glomerular epithelial cells using laboratory strains of HIV-1 have proven fruitless. The striking morphologic and phenotypic similarities between HIVAN and collapsing idiopathic FSGS raise the question whether the altered podocyte gene expression in collapsing idiopathic FSGS may also be due to a viral infection. This hypothesis is further supported by de novo occurrence of collapsing idiopathic FSGS in immunosuppressed renal transplantation patients and by epidemiologic data. In conclusion, there are likely to be common mechanisms in the pathogenesis for collapsing idiopathic glomerulosclerosis and HIVAN. A primary injury of the podocyte leading to dysregulation of the cellular phenotype appears to mediate the glomerular tuft collapse in both conditions. Primary collapsing glomerulopathy recurs post-transplantation, raising the possibility of circulating factors implicated in the pathogenesis of visceral epithelial cell damage in steroid-resistant minimal change disease or recurrent FSGS. Recurrence of CG can occur hours after transplantation, suggesting that the plasma of CG patients contains one or more factors capable of inducing proteinuria due to the damage of the podocyte that results in the increase in glomerular permeability. In a rat model of CG developed by our group, the injection of serum from CG patients resulted in proteinuria, glomerular tuft retraction and podocyte damage at the ultrastructural level (visceral epithelial cell footprocess effacement). No ultrastructural or light microscopy abnormalities were seen in rats injected with serum from non-collapsing FSGS or healthy subjects. Based on the experience of our group, circulating factors play a dominant role in the pathogenesis of idiopathic CG.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. World Health Organization: Global Summary of the HIV/AIDS Statistics. UNAIDS Progress Report 2009 (Epiupdate) Geneva, WHO, 2009.;
  2. D’Agati V Appel GB: HIV infection and the kidney. J Am Soc Nephrol 2005; 16: 2403-2411
  3. Gardenswartz MH Lerner CW Seligson OR Zabetakis PM Rotterdam H Tapper ML Michelis MF Bruno MS: Renal disease in patients with AIDS: a clinicopathologic study. Clin Nephrol 1984; 21: 197-204
  4. Soriano Rosas J Avila- Casado MC Carrera- González E Chavez-Mercado L Cruz Ortiz H Rojo J: AIDS-associated nephropathy: 5-year retrospective morphologic analysis of 87 cases. Pathol Res Pract 1998; 194: 567-570
  5. Barisoni L Bruggeman LA Mundel P D’Agati VD Klotman PE: HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney Int 2000; 58: 173-181
  6. Barisoni L Kriz W Mundel P D’Agati V: The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 1999; 10: 51-61
  7. Dickie P Felser J Eckhaus M Bryant J Silver J Marinos N Notkins AL: HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 1991; 185: 109-119
  8. D’Agati V Suh JI Carbone L Cheng IT Appel G: The pathology of HIV nephropathy: a detailed morphologic and comparative study. Kidney Int 1989; 35: 1358-1370
  9. Itescu S Brancato LI Buxbaum I Oregersen PK Rizk CC Croxson S Solomon O Winchester R: A diffuse infiltrative CD8 lymphocytosis syndrome in human (HIV) infection: a host immune response associated with HLADR5. Ann Intern Med 1990; 12: 3-10
  10. Itescu S Brancato LI Winchester R: A sicca syndrome in HIV infection: association with HLA-DR5 and CD8 lymphocytosis. Lancet 1989; 2: 466-468
  11. Itescu S Rose S Dwyer E Winchester R: Certain HLA-DR5 and -DR6 major histocompatibility complex class II alleles are associated with a CD8 lymphocytic host response to human immunodeficiency virus type I characterized by low lymphocyte viral strain heterogeneity and slow disease progression. Proc Natl Acad Sci USA 1994; 91: 11472-11476
  12. Bruggeman LA Dikman S Meng C Quaggin SE Coffman TM Klotman PE: Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 1997; 100: 84-92
  13. Conaldi PG Biancone L Bottelli A Wade-Evans A Racusen LC Boccellino M Orlandi V Serra C Camussi G Toniolo A: HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. J Clin Invest 1998; 102: 2041-2049
  14. Albert I Olausson E AsJo B: Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol 1988; 62: 4414-4419
  15. Cboyd NW Moore BE: Spectrum of biological properties of human immunodeficiency virus (HIV-l) isolates. J Virol 1990; 174: 103-106
  16. Zhu T Mo H Wang N Nam DS Cao Y Koup RA Ho DD: Oenotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993; 261: 1179-1181
  17. Karlsson-Parra A Dimeney E Fellstrom B Klarkeskog L: HIV receptors (CD4 antigen) in normal human glomerular cells. N Engl J Med 1989; 320: 741-747
  18. Green DF Resnick L Bourgoignie JJ: HIV infects glomerular endothelial and mesangial but not epithelial cells in vitro. Kidney Int 1992; 4: (l) 956-960
  19. Alpers CE McClure I Bursten SL: Human mesangial cells are resistant to productive infection by multiple strains of human immunodeficiency virus types 1 and 2. Am J Kidney Dis 1992; 19: 126-130
  20. Nadasdy T Hanson-Painton O Davis LD Miller KW DeBault L Burns D Silva FG: Conditions affecting the immunohistochemical detection of HIV in fixed and embedded renal and nonrenal tissues. Mod Pathol 1992; 5: 283-291
  21. Pardo V Shapshak P Yoshioka M et al: HIV-associated nephropathy (HIVN): Direct viral invasion or indirect glomerular involvement (abstract). FASEB J 1991; 5: 907A
  22. Striker GE Mannik M Tung MY: Role of marrow-derived monocytes and mesangial cells in removal of immune complexes from renal glomeruli. J Exp Med 1979; 149: 127-136
  23. Nagata M Kriz W: Glomerular damage after uninephrectomy in young rats. II. Mechanical stress of podocytes as a pathway to sclerosis Kidney Int 1992; 42: 148-160
  24. Clapham PR Weber in Whitby D Mcintosh K Daloleish AG Maddon PT Deen KC Swet RW Weiss RA: Soluble CD4 blocks the infectivity of diverse strains of HIV and SlY for T cells and monocytes but not for brain and muscle cells. Nature 1989; 337: 368-370
  25. Mckeating JA Griffiths PD Weiss RA: HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fe receptor. Nature 1990; 343: 659-661
  26. Raffanti S Svennigsson A Resnick L: HIV-l infection of CD4 negative cells via HTLV pseudoviruses. AIDS 1991; 5: 769-772
  27. Kajiyama W Kopp JB Marinos NJ Klotman PE Dickie P: Glomerulosclerosis and viral gene expression in HIV-transgenic mice. Kidney Int 2000; 58: 1148-1159
  28. Bruggeman LA Dikman S Meng Ch Quaggin SE Coffman TM Klotman PE: Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clinical Invest 1997; 100: 84-92
  29. Dantal J Bigot E Bogers W et al: Effect of plasma protein adsorption on protein excretion in kidneytransplant recipient with recurrent nephrotic syndrome. N Engl J Med 1994; 30: 7-14
  30. Cheung PK Klok PA Bakker WW: Minimal change-like alterations induced by a human plasma factor. Nephron 1996; 74: 586-593
  31. Marras D Bruggeman LA Gao F et al: Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med 2002; 8: 522-524
  32. Ray PE Liu XH Henry D Dye L Xu L Orenstein JM Schutzbank TE: Infection of human primary renal epithelial cells with HIV-1 from children with HIV-associated nephropathy. Kidney Int, 1998; 53: 1217-1229
  33. Kopp JB Klotman ME Adler SH Bruggeman LA Dickie P Marinos NJ Eckhaus M Bryant JL Notkins AL Klotman PE: Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for HIV-1 genes. Proc Natl Acad Sci USA 1992; 89: 1577-1582
  34. Kemeny E Durmuller U Nickeleit V Gudat F Mihatsch MJ: Distribution of podocyte protein (44 kD) in different types of glomerular diseases. Virchows Arch 1997; 431: 425-430
  35. Kreidberg JA Sariola H Loring JM Maeda M Pelletier J Housman D Jaenisch R: WT-1 is required for early kidney development. Cell 1993; 74: 679-691
  36. Thomas PE Wharram BL Goyal M Wiggins JE Holzman LB Wiggins RC: GLEPP-1, a renal glomerular epithelial (podocyte) membrane protein tyrosine phosphatase: identification, molecular cloning, and characterization in rabbit. J Biol Chem 1994; 269: 19953-19962
  37. Mundel P Gilbert P Kriz W: Podocytes in glomerulus of rat kidney express a characteristic 44 kD protein. J Histochem Cytochem 1991; 39: 1047-1056
  38. D’Agati V: The many masks of focal segmental glomerulosclerosis. Kidney Int 1994; 46: 1223-1241
  39. Rennke HG: How does glomerular epithelial cell injury contribute to progressive glomerular damage?. Kidney Int 1994; 45: S58-S63
  40. Kriz W: Progressive renal failureinability of podocytes to replicate and the consequences for development of glomerulosclerosis. Nephrol Dial Transplant 1996; 11: 1738-1742
  41. Kriz W Gretz N Lemley KV: Progression of glomerular diseases: is the podocyte the culprit?. Kidney Int 1998; 54: 687-697
  42. Sharif K Goyal M Kershaw D Kunkel R Wiggins R: Podocyte phenotypes as defined by expression and distribution of GLEPP-1 in the developing glomerulus and in nephrotic glomeruli from MCD, CNF, and FSGS: a dedifferentiation hypothesis for the nephrotic syndrome. Exp Nephrol 1998; 6: 234-244
  43. Kriz W Hähnel B Rösener S Elger M: Long-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis. Kidney Int 1995; 48: 1435-1450
  44. Shankland SJ: Cell-cycle control and renal disease. Kidney Int 1997; 52: 294-308
  45. Kitamoto Y Tokunaga H Tomita K: Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis. J Clin Invest 1997; 99: 2351-2357
  46. Weiss MA Daquioag E Margolin EG Pollak VE: Nephrotic syndrome, progressive irreversible renal failure, and glomerular ‘collapse’: a new clinicopathologic entity?. Am J Kidney Dis 1986; 7: 20-28
  47. Avila-Casado C Galvanek EG Rennke HG: Collapsing Glomerulopathy (CG) developing in the renal allograft (abstract). J Am Soc Nephrol 1994; 5: 994
  48. Stokes MB Davis CL Alpers CE: Collapsing glomerulopathy in renal allografts: a morphological pattern with diverse clinicopathological associations. Am J Kidney Dis 1999; 33: 658-666
  49. Avila-Casado MC Perez-Torres I Auron A Soto V Fortoul TI Herrera-Acosta J: Proteinuria in rats induced by serum from patients with collapsing glomerulopathy. Kidney Int 2004; 66: 133-143
  50. Artero ML Sharma R Savin VI et al: plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994; 23: 574-581
  51. Gornall AG Bardawill CJ Davis M: Determination of serum proteins by means of Biuret reaction. J Biol Chem 1949; 177: 751-766
  52. Smith SR Suetkey LP Dennis VA: Racial differences in the incidence and progression of renal diseases. Kidney Int 1991; 40: 815-822
  53. Avila-Casado C Perez-Torres I Bochicchio T Torres-Rosales A Lopez E Niño JA Fortoul TI: Clinical characteristics and outcomes in FSGS patients with circulating factors (abstract). J Am Soc Nephrol 2007; 18: 565A


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50